The recent financing round has raised Clarium’s total capital to $16m. Credit: Frederick Warren / Unsplash.

US-based healthcare technology company Clarium has garnered $10.5m in a funding round, which was led by General Catalyst.

Other contributors to this fundraiser included Kaiser Permanente Ventures, Yale New Haven Health, and Texas Medical Center Venture Fund, along with existing investors such as AlleyCorp, 1984 Ventures, and Alumni Ventures.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The investment will help expand the health tech’s talent pool in various areas covering engineering, sales, and data science, as well as aid its technological investments, including in generative artificial intelligence (AI).

Clarium also intends to use the funds to enhance integration with existing partners such as CommonSpirit, Yale New Haven Health, and others. The goal is to develop programmes with more health systems and refine the platform’s product line-up.

The recent financing round has raised Clarium’s total capital to $16m.

See Also:

In addition, the company introduced Astra OS, an AI-based workflow and data platform designed to optimise supply chain operations. Health system partners using this platform have reportedly tracked cost savings of over $10m and significant productivity gains.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Clarium’s Astra OS has been said to be instrumental in reducing disruption resolution time by 50%, lowering substitute approval time by 63%, and increasing the approval of clinically validated substitutes by 3.7 times.

The healthcare industry faces hurdles with fragmented data, leading to overspending on supply chain operations and related operations by more than $25bn annually. Clarium aims to address these issues.

Commenting on the impact of Astra OS, Clarium founder and CEO Steve Liou stated: “Our AI-powered platform and data ecosystem, Astra OS, brings hospitals and providers to the cutting edge of technology and helps to dramatically optimise spend, enhance workforce productivity, and ultimately improve patient outcomes.”

General Catalyst partner Reva Nohria added: “Clarium’s Astra OS is aiming to fill a market gap with its end-to-end enterprise platform for supply chain operations. Through deep integrations and the application of generative AI, we believe Clarium will drive a paradigm shift in supply chain efficiency.”